JoAnne McLaurin
Affiliations: |
Google:
"JoAnne McLaurin"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rybnicek J, Chen Y, Milic M, et al. (2024) CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer's disease. Translational Psychiatry. 14: 83 |
| Morrone CD, Lai AY, Bishay J, et al. (2022) Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease. Translational Neurodegeneration. 11: 26 |
| Lai AY, Joo IL, Trivedi AU, et al. (2021) Cerebrovascular damage after midlife transient hypertension in non-transgenic and Alzheimer's disease rats. Brain Research. 147369 |
| Liu M, Beckett T, Am Thomason L, et al. (2021) Covert strokes prior to Alzheimer's disease onset accelerate peri-lesional pathology but not cognitive deficits in an inducible APP mouse model. Brain Research. 147233 |
| Morrone CD, Bishay J, McLaurin J. (2020) Potential Role of Venular Amyloid in Alzheimer's Disease Pathogenesis. International Journal of Molecular Sciences. 21 |
| Morrone CD, Bazzigaluppi P, Beckett TL, et al. (2019) Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation. Brain : a Journal of Neurology |
| Proulx É, Power SK, Oliver DK, et al. (2019) Apamin Improves Prefrontal Nicotinic Impairment in Mouse Model of Alzheimer's Disease. Cerebral Cortex (New York, N.Y. : 1991) |
| Liu M, Jevtic S, Markham-Coultes K, et al. (2017) Investigating the efficacy of a combination Aβ-targeted treatment in a mouse model of Alzheimer's disease. Brain Research |
| Bazzigaluppi P, Beckett TL, Koletar MM, et al. (2017) Early stage attenuation of phase amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of AD. Journal of Neurochemistry |
| Lai AY, McLaurin J. (2017) Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. Journal of Neurochemistry |